IM Cannabis (IMCC) Revenue & Revenue Breakdown
IM Cannabis Revenue Highlights
Latest Revenue (Y)
$48.80M
Latest Revenue (Q)
$12.06M
Main Geography (Y)
ISRAEL
IM Cannabis Revenue by Period
IM Cannabis Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $48.80M | -10.18% |
| 2022-12-31 | $54.34M | 0.06% |
| 2021-12-31 | $54.30M | 241.72% |
| 2020-12-31 | $15.89M | 75.12% |
| 2019-12-31 | $9.07M | 74.60% |
| 2019-04-30 | $5.20M | 100.00% |
| 2018-04-30 | - | 100.00% |
| 2017-04-30 | - | 100.00% |
| 2016-04-30 | - | 100.00% |
| 2014-04-30 | - | 100.00% |
| 2013-04-30 | - | 100.00% |
| 2012-04-30 | - | 100.00% |
| 2011-04-30 | - | 100.00% |
| 2010-04-30 | - | 100.00% |
| 2009-04-30 | - | 100.00% |
| 2008-04-30 | - | 100.00% |
| 2007-04-30 | - | 100.00% |
| 2006-04-30 | - | 100.00% |
| 2005-04-30 | - | 100.00% |
| 2004-04-30 | - | 100.00% |
| 2003-04-30 | - | -100.00% |
| 2002-04-30 | $34.58K | -68.81% |
| 2001-04-30 | $110.89K | 10.89% |
| 2000-04-30 | $100.00K | - |
| 1999-04-30 | $100.00K | -83.33% |
| 1998-04-30 | $600.00K | -45.45% |
| 1997-04-30 | $1.10M | - |
IM Cannabis generated $48.80M in revenue during NA 2023, up -10.18% compared to the previous quarter, and up 939.08% compared to the same period a year ago.
IM Cannabis Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $12.06M | 12.76% |
| 2023-12-31 | $10.70M | -71.93% |
| 2023-09-30 | $38.11M | 188.53% |
| 2023-06-30 | $13.21M | 0.26% |
| 2023-03-31 | $13.17M | -8.91% |
| 2022-12-31 | $14.46M | 2.05% |
| 2022-09-30 | $14.17M | -40.51% |
| 2022-06-30 | $23.82M | 1.07% |
| 2022-03-31 | $23.57M | 17.68% |
| 2021-12-31 | $20.03M | 39.15% |
| 2021-09-30 | $14.39M | 29.53% |
| 2021-06-30 | $11.11M | 26.75% |
| 2021-03-31 | $8.77M | 78.92% |
| 2020-12-31 | $4.90M | -16.85% |
| 2020-09-30 | $5.89M | 56.85% |
| 2020-06-30 | $3.76M | 180.37% |
| 2020-03-31 | $1.34M | -45.95% |
| 2019-12-31 | $2.48M | 6.58% |
| 2019-09-30 | $2.33M | 0.52% |
| 2019-07-31 | $2.31M | 18.36% |
| 2019-04-30 | $1.96M | 100.00% |
| 2019-01-31 | - | -100.00% |
| 2018-09-30 | $1.38M | 100.00% |
| 2018-07-31 | - | -100.00% |
| 2018-04-30 | $1.10M | 100.00% |
| 2018-01-31 | - | 100.00% |
| 2017-10-31 | - | 100.00% |
| 2017-07-31 | - | 100.00% |
| 2017-04-30 | - | 100.00% |
| 2017-01-31 | - | 100.00% |
| 2016-10-31 | - | 100.00% |
| 2016-07-31 | - | 100.00% |
| 2015-01-31 | - | 100.00% |
| 2014-10-31 | - | 100.00% |
| 2014-07-31 | - | 100.00% |
| 2014-04-30 | - | 100.00% |
| 2014-01-31 | - | 100.00% |
| 2013-10-31 | - | 100.00% |
| 2013-07-31 | - | 100.00% |
| 2013-04-30 | - | 100.00% |
| 2013-01-31 | - | 100.00% |
| 2012-10-31 | - | 100.00% |
| 2012-07-31 | - | 100.00% |
| 2012-04-30 | - | 100.00% |
| 2012-01-31 | - | 100.00% |
| 2011-10-31 | - | 100.00% |
| 2011-07-31 | - | 100.00% |
| 2011-04-30 | - | 100.00% |
| 2011-01-31 | - | 100.00% |
| 2010-10-31 | - | 100.00% |
| 2010-07-31 | - | 100.00% |
| 2010-04-30 | - | 100.00% |
| 2010-01-31 | - | 100.00% |
| 2009-10-31 | - | 100.00% |
| 2009-07-31 | - | 100.00% |
| 2009-04-30 | - | 100.00% |
| 2009-01-31 | - | 100.00% |
| 2008-10-31 | - | 100.00% |
| 2008-07-31 | - | 100.00% |
| 2008-04-30 | - | 100.00% |
| 2008-01-31 | - | 100.00% |
| 2007-10-31 | - | 100.00% |
| 2007-07-31 | - | 100.00% |
| 2007-04-30 | - | 100.00% |
| 2007-01-31 | - | 100.00% |
| 2006-10-31 | - | 100.00% |
| 2006-07-31 | - | 100.00% |
| 2006-04-30 | - | 100.00% |
| 2005-04-30 | - | 100.00% |
| 2004-10-31 | - | 100.00% |
| 2004-07-31 | - | 100.00% |
| 2004-04-30 | - | 100.00% |
| 2003-10-31 | - | 100.00% |
| 2003-07-31 | - | 100.00% |
| 2003-04-30 | - | 100.00% |
| 2002-10-31 | - | 100.00% |
| 2002-07-31 | - | 100.00% |
| 2002-04-30 | - | -100.00% |
| 2001-10-31 | $7.30K | - |
IM Cannabis generated $12.06M in revenue during Q1 2024, up 12.76% compared to the previous quarter, and up 83.42% compared to the same period a year ago.
IM Cannabis Revenue Breakdown
IM Cannabis Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 |
|---|---|
| ISRAEL | $43.32M |
IM Cannabis's latest annual revenue breakdown by geography, as of Dec 23: ISRAEL (100.00%).
IM Cannabis Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PAHC | Phibro Animal Health | $977.89M | $263.22M |
| SUPN | Supernus Pharmaceuticals | $607.52M | $168.32M |
| IMCC | IM Cannabis | $48.80M | $12.06M |
| QLI | Qilian Group | $46.47M | $17.31M |
| BFRI | Biofrontera | $34.01M | $7.83M |
| UPC | Universe Pharmaceuticals | $32.31M | $13.84M |
| CLVR | Clever Leaves | $17.42M | $4.64M |
| SSIC | Silver Spike Investment | $11.72M | $2.76B |
| IXHL | Incannex Healthcare | - | - |
IMCC Revenue FAQ
What is IM Cannabis’s yearly revenue?
IM Cannabis's yearly revenue for 2023 was $48.8M, representing a decrease of -10.18% compared to 2022. The company's yearly revenue for 2022 was $54.34M, representing an increase of 0.06% compared to 2021. IMCC's yearly revenue for 2021 was $54.3M, representing an increase of 241.72% compared to 2020.
What is IM Cannabis’s quarterly revenue?
IM Cannabis's quarterly revenue for Q1 2024 was $12.06M, a 12.76% increase from the previous quarter (Q4 2023), and a -8.43% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $10.7M, a -71.93% decrease from the previous quarter (Q3 2023), and a -26.02% decrease year-over-year (Q4 2022). IMCC's quarterly revenue for Q3 2023 was $38.11M, a 188.53% increase from the previous quarter (Q2 2023), and a 168.92% increase year-over-year (Q3 2022).
What is IM Cannabis’s revenue growth rate?
IM Cannabis's revenue growth rate for the last 3 years (2021-2023) was -10.12%, and for the last 5 years (2019-2023) was 437.84%.